$502 Million is the total value of Ikarian Capital, LLC's 104 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 86.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RLMD | Buy | RELMADA THERAPEUTICS INCput | $28,703,000 | +435.3% | 775,300 | +174.6% | 5.72% | +484.9% |
RLMD | Buy | RELMADA THERAPEUTICS INCcall | $28,701,000 | +403.7% | 775,300 | +158.4% | 5.72% | +450.4% |
SPY | New | SPDR S&P 500 ETF TRput | $21,431,000 | – | 60,000 | +100.0% | 4.27% | – |
SGEN | New | SEAGEN INCcall | $20,525,000 | – | 150,000 | +100.0% | 4.09% | – |
BIIB | Sell | BIOGEN INCcall | $18,825,000 | -17.7% | 70,500 | -37.2% | 3.75% | -10.1% |
AXSM | Sell | AXSOME THERAPEUTICS INCput | $18,188,000 | -5.0% | 407,600 | -18.5% | 3.62% | +3.8% |
ISEE | Buy | IVERIC BIO INC | $17,559,000 | +3612.3% | 978,783 | +1893.5% | 3.50% | +3968.6% |
New | DICE THERAPEUTICS INCcall | $15,188,000 | – | 748,900 | +100.0% | 3.03% | – | |
ESPR | Buy | ESPERION THERAPEUTICS INC NE | $14,278,000 | +9.3% | 2,131,147 | +3.7% | 2.84% | +19.4% |
BIIB | New | BIOGEN INCput | $14,204,000 | – | 53,200 | +100.0% | 2.83% | – |
RXDX | New | PROMETHEUS BIOSCIENCES INC | $13,641,000 | – | 231,181 | +100.0% | 2.72% | – |
XBI | Sell | SPDR SER TRput | $11,898,000 | -54.2% | 150,000 | -57.1% | 2.37% | -50.0% |
ALT | Buy | ALTIMMUNE INCcall | $10,762,000 | +202.9% | 842,600 | +177.5% | 2.14% | +231.0% |
RXDX | New | PROMETHEUS BIOSCIENCES INCcall | $10,504,000 | – | 178,000 | +100.0% | 2.09% | – |
New | DICE THERAPEUTICS INCput | $10,223,000 | – | 504,100 | +100.0% | 2.04% | – | |
SRPT | Sell | SAREPTA THERAPEUTICS INCcall | $9,418,000 | +25.7% | 85,200 | -14.8% | 1.88% | +37.3% |
DCPH | New | DECIPHERA PHARMACEUTICALS IN | $9,107,000 | – | 492,275 | +100.0% | 1.82% | – |
BLU | Sell | BELLUS HEALTH INC NEW | $8,977,000 | -4.6% | 850,134 | -16.5% | 1.79% | +4.3% |
CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $8,924,000 | -38.5% | 317,476 | -41.0% | 1.78% | -32.8% |
MIST | Sell | MILESTONE PHARMACEUTICALS IN | $7,863,000 | -4.0% | 855,616 | -38.0% | 1.57% | +4.9% |
ISEE | Buy | IVERIC BIO INCcall | $7,856,000 | +234.2% | 437,900 | +79.2% | 1.56% | +264.8% |
TCDA | Buy | TRICIDA INCput | $7,628,000 | +748.5% | 727,900 | +683.5% | 1.52% | +826.8% |
GOSS | Sell | GOSSAMER BIO INC | $7,313,000 | -12.7% | 610,407 | -39.0% | 1.46% | -4.6% |
Sell | AMYLYX PHARMACEUTICALS INCcall | $7,037,000 | +4.1% | 250,000 | -28.7% | 1.40% | +13.8% | |
KRYS | New | KRYSTAL BIOTECH INCput | $6,635,000 | – | 95,200 | +100.0% | 1.32% | – |
Buy | ASTRIA THERAPEUTICS INC | $6,322,000 | +256.0% | 699,440 | +18.1% | 1.26% | +288.9% | |
GOSS | Buy | GOSSAMER BIO INCcall | $6,308,000 | +125.3% | 526,600 | +57.4% | 1.26% | +146.0% |
KZR | Sell | KEZAR LIFE SCIENCES INC | $6,273,000 | -46.1% | 728,586 | -48.3% | 1.25% | -41.1% |
SAGE | New | SAGE THERAPEUTICS INC | $6,180,000 | – | 157,805 | +100.0% | 1.23% | – |
TCDA | New | TRICIDA INCcall | $6,054,000 | – | 577,600 | +100.0% | 1.21% | – |
ALT | Sell | ALTIMMUNE INC | $6,028,000 | -42.6% | 472,054 | -47.4% | 1.20% | -37.3% |
XENE | Sell | XENON PHARMACEUTICALS INC | $5,794,000 | -20.4% | 160,486 | -33.0% | 1.16% | -13.0% |
TERN | Buy | TERNS PHARMACEUTICALS INC | $5,326,000 | +206.8% | 904,119 | +29.2% | 1.06% | +234.7% |
ACAD | New | ACADIA PHARMACEUTICALS INC | $5,317,000 | – | 325,000 | +100.0% | 1.06% | – |
HZNP | Sell | HORIZON THERAPEUTICS PUB Lcall | $5,267,000 | -34.0% | 85,100 | -14.9% | 1.05% | -27.8% |
CERE | New | CEREVEL THERAPEUTICS HLDNG I | $5,033,000 | – | 178,100 | +100.0% | 1.00% | – |
STOK | New | STOKE THERAPEUTICS INCput | $4,734,000 | – | 368,700 | +100.0% | 0.94% | – |
TCON | Sell | TRACON PHARMACEUTICALS INC | $4,618,000 | -17.2% | 2,765,530 | -0.8% | 0.92% | -9.5% |
HZNP | Sell | HORIZON THERAPEUTICS PUB L | $4,593,000 | -64.0% | 74,219 | -53.6% | 0.92% | -60.7% |
IMVT | New | IMMUNOVANT INC | $4,529,000 | – | 811,700 | +100.0% | 0.90% | – |
ARVN | New | ARVINAS INCcall | $4,450,000 | – | 100,000 | +100.0% | 0.89% | – |
PRTA | New | PROTHENA CORP PLCcall | $4,050,000 | – | 66,800 | +100.0% | 0.81% | – |
ARDX | Buy | ARDELYX INC | $3,784,000 | +281.8% | 3,178,825 | +89.2% | 0.75% | +316.6% |
ABOS | New | ACUMEN PHARMACEUTICALS INC | $3,511,000 | – | 350,000 | +100.0% | 0.70% | – |
PNT | New | POINT BIOPHARMA GLOBAL INC | $3,482,000 | – | 450,406 | +100.0% | 0.69% | – |
RETA | Sell | REATA PHARMACEUTICALS INCcall | $3,470,000 | -29.5% | 138,100 | -14.8% | 0.69% | -23.1% |
AVTE | New | AEROVATE THERAPEUTICS INC | $3,316,000 | – | 200,000 | +100.0% | 0.66% | – |
ARKG | New | ARK ETF TRgenomic rev etf | $3,171,000 | – | 96,462 | +100.0% | 0.63% | – |
SCPH | Sell | SCPHARMACEUTICALS INC | $3,126,000 | -26.6% | 479,383 | -45.8% | 0.62% | -19.8% |
MIST | New | MILESTONE PHARMACEUTICALS INput | $3,107,000 | – | 338,000 | +100.0% | 0.62% | – |
BLUE | New | BLUEBIRD BIO INC | $2,928,000 | – | 462,628 | +100.0% | 0.58% | – |
BIIB | Buy | BIOGEN INC | $2,926,000 | +1183.3% | 10,962 | +877.0% | 0.58% | +1288.1% |
RVNC | New | REVANCE THERAPEUTICS INC | $2,700,000 | – | 100,000 | +100.0% | 0.54% | – |
COGT | Sell | COGENT BIOSCIENCES INC | $2,429,000 | +7.7% | 162,766 | -34.9% | 0.48% | +17.8% |
STSA | New | SATSUMA PHARMACEUTICALS INCcall | $2,400,000 | – | 400,000 | +100.0% | 0.48% | – |
DCPH | New | DECIPHERA PHARMACEUTICALS INcall | $2,268,000 | – | 122,600 | +100.0% | 0.45% | – |
INSM | New | INSMED INCcall | $2,154,000 | – | 100,000 | +100.0% | 0.43% | – |
SRPT | Sell | SAREPTA THERAPEUTICS INC | $1,858,000 | -0.9% | 16,809 | -32.8% | 0.37% | +8.2% |
LYRA | Sell | LYRA THERAPEUTICS INC | $1,722,000 | -12.3% | 343,685 | -1.1% | 0.34% | -4.2% |
MIST | Sell | MILESTONE PHARMACEUTICALS INcall | $1,657,000 | +31.4% | 180,300 | -15.1% | 0.33% | +43.5% |
New | CINCOR PHARMA INC | $1,481,000 | – | 45,100 | +100.0% | 0.30% | – | |
AKRO | New | AKERO THERAPEUTICS INCcall | $1,392,000 | – | 40,900 | +100.0% | 0.28% | – |
ESPR | New | ESPERION THERAPEUTICS INC NEcall | $1,339,000 | – | 200,000 | +100.0% | 0.27% | – |
VKTX | Sell | VIKING THERAPEUTICS INC | $1,260,000 | -47.8% | 463,156 | -44.6% | 0.25% | -43.0% |
ICPT | Sell | INTERCEPT PHARMACEUTICALS IN | $1,189,000 | -17.9% | 85,200 | -18.9% | 0.24% | -10.2% |
GERN | New | GERON CORPcall | $1,170,000 | – | 500,000 | +100.0% | 0.23% | – |
ETNB | New | 89BIO INC | $1,158,000 | – | 200,000 | +100.0% | 0.23% | – |
OCUL | New | OCULAR THERAPEUTIX INC | $1,099,000 | – | 265,000 | +100.0% | 0.22% | – |
XFOR | Sell | X4 PHARMACEUTICALS INC | $973,000 | -40.0% | 568,612 | -66.1% | 0.19% | -34.5% |
CLNN | New | CLENE INCcall | $903,000 | – | 322,600 | +100.0% | 0.18% | – |
BLU | Sell | BELLUS HEALTH INC NEWcall | $900,000 | -2.6% | 85,200 | -14.8% | 0.18% | +6.5% |
MCRB | Sell | SERES THERAPEUTICS INC | $843,000 | -54.5% | 131,310 | -75.7% | 0.17% | -50.3% |
BCLI | Sell | BRAINSTORM CELL THERAPEUTICS | $839,000 | +20.2% | 189,935 | -25.1% | 0.17% | +31.5% |
DSGN | New | DESIGN THERAPEUTICS INCput | $811,000 | – | 48,500 | +100.0% | 0.16% | – |
STSA | Sell | SATSUMA PHARMACEUTICALS INC | $815,000 | -69.9% | 136,059 | -79.2% | 0.16% | -67.1% |
Sell | RENOVACOR INC | $725,000 | +21.8% | 288,119 | -1.8% | 0.14% | +33.3% | |
ELDN | Sell | ELEDON PHARMACEUTICALS INC | $612,000 | -30.8% | 221,830 | -38.8% | 0.12% | -24.2% |
CMMB | Sell | CHEMOMAB THERAPEUTICS LTDsponsored ads | $612,000 | -38.3% | 245,896 | -8.3% | 0.12% | -32.6% |
ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $560,000 | -93.7% | 2,800 | -95.4% | 0.11% | -93.1% |
AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $556,000 | -39.0% | 260,087 | -19.3% | 0.11% | -33.1% |
TARA | Sell | PROTARA THERAPEUTICS INC | $558,000 | -26.2% | 188,664 | -26.8% | 0.11% | -19.6% |
Sell | BELLICUM PHARMACEUTICALS INC | $537,000 | -13.0% | 448,101 | -14.4% | 0.11% | -5.3% | |
RPHM | Sell | RENEO PHARMACEUTICALS INC | $521,000 | +6.1% | 155,819 | -16.0% | 0.10% | +15.6% |
CLNN | New | CLENE INCput | $496,000 | – | 177,400 | +100.0% | 0.10% | – |
IMTX | Sell | IMMATICS N.V | $490,000 | -64.2% | 49,031 | -68.8% | 0.10% | -60.8% |
RETA | New | REATA PHARMACEUTICALS INCput | $463,000 | – | 18,400 | +100.0% | 0.09% | – |
ANEB | Sell | ANEBULO PHARMACEUTICALS INC | $437,000 | -53.6% | 156,203 | -13.8% | 0.09% | -49.4% |
CLVS | Sell | CLOVIS ONCOLOGY INC | $430,000 | -43.5% | 361,518 | -14.4% | 0.09% | -38.1% |
FNCH | Sell | FINCH THERAPEUTICS GROUP INC | $397,000 | -57.7% | 237,553 | -28.1% | 0.08% | -53.8% |
SYBX | Sell | SYNLOGIC INC | $292,000 | -46.4% | 306,757 | -35.3% | 0.06% | -41.4% |
CNTB | Sell | CONNECT BIOPHARMA HLDGS LTDads | $283,000 | -52.1% | 219,501 | -67.6% | 0.06% | -48.1% |
GOSS | New | GOSSAMER BIO INCput | $209,000 | – | 17,400 | +100.0% | 0.04% | – |
VRNA | Buy | VERONA PHARMA PLCsponsored ads | $193,000 | -3.5% | 315,131 | +5.0% | 0.04% | +5.6% |
ARKK | New | ARK ETF TRinnovation etf | $171,000 | – | 4,519 | +100.0% | 0.03% | – |
PRAX | Sell | PRAXIS PRECISION MEDICINES Icall | $168,000 | -36.1% | 74,200 | -30.8% | 0.03% | -31.2% |
ASLN | Sell | ASLAN PHARMACEUTICALS LTDads | $146,000 | -21.1% | 820,455 | -15.5% | 0.03% | -14.7% |
MITO | Sell | STEALTH BIOTHERAPEUTICS CORPsponsored ads | $134,000 | +5.5% | 435,516 | -13.2% | 0.03% | +17.4% |
CABA | Sell | CABALETTA BIO INC | $109,000 | -89.1% | 168,623 | -82.1% | 0.02% | -87.9% |
RETA | Sell | REATA PHARMACEUTICALS INCcl a | $102,000 | -83.9% | 4,064 | -80.5% | 0.02% | -82.6% |
SPPI | New | SPECTRUM PHARMACEUTICALS INC | $76,000 | – | 176,980 | +100.0% | 0.02% | – |
CRBP | Sell | CORBUS PHARMACEUTICALS HLDGS | $66,000 | -69.6% | 397,168 | -54.0% | 0.01% | -67.5% |
IVA | Sell | INVENTIVA SAads | $48,000 | -48.4% | 13,236 | -15.0% | 0.01% | -41.2% |
OTIC | Exit | OTONOMY INC | $0 | – | -180 | -100.0% | 0.00% | – |
ERYP | New | ERYTECH PHARMAsponsored adr | $2,000 | – | 3,019 | +100.0% | 0.00% | – |
KDNY | Sell | CHINOOK THERAPEUTICS INC | $0 | – | 283,464 | -14.7% | 0.00% | – |
Exit | BAUDAX BIO INC | $0 | – | -2,966 | -100.0% | -0.00% | – | |
Exit | ALTAMIRA THERAPEUTICS LTD | $0 | – | -75,000 | -100.0% | -0.01% | – | |
ENVB | Exit | ENVERIC BIOSCIENCES INC | $0 | – | -223,834 | -100.0% | -0.01% | – |
OVID | Exit | OVID THERAPEUTICS INC | $0 | – | -26,831 | -100.0% | -0.01% | – |
MNMD | Exit | MIND MEDICINE MINDMED INC | $0 | – | -105,958 | -100.0% | -0.01% | – |
Exit | BRIGHT MINDS BIOSCIENCES INC | $0 | – | -105,958 | -100.0% | -0.02% | – | |
LRMR | Exit | LARIMAR THERAPEUTICS INC | $0 | – | -51,606 | -100.0% | -0.02% | – |
CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -104,741 | -100.0% | -0.02% | – |
TPST | Exit | TEMPEST THERAPEUTICS INC | $0 | – | -61,827 | -100.0% | -0.02% | – |
MBIO | Exit | MUSTANG BIO INC | $0 | – | -246,824 | -100.0% | -0.03% | – |
CLNN | Exit | CLENE INC | $0 | – | -70,000 | -100.0% | -0.03% | – |
Exit | MYMD PHARMACEUTICALS INC | $0 | – | -81,089 | -100.0% | -0.03% | – | |
YMTX | Exit | YUMANITY THERAPEUTICS INC | $0 | – | -104,392 | -100.0% | -0.04% | – |
MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -615,856 | -100.0% | -0.04% | – |
IMUX | Exit | IMMUNIC INC | $0 | – | -61,500 | -100.0% | -0.04% | – |
IMUX | Exit | IMMUNIC INCput | $0 | – | -61,500 | -100.0% | -0.04% | – |
Exit | REGULUS THERAPEUTICS INC | $0 | – | -105,341 | -100.0% | -0.04% | – | |
HEPA | Exit | HEPION PHARMACEUTICALS INC | $0 | – | -410,189 | -100.0% | -0.04% | – |
IPA | Exit | IMMUNOPRECISE ANTIBODIES LTD | $0 | – | -61,433 | -100.0% | -0.04% | – |
VSTM | Exit | VERASTEM INC | $0 | – | -228,023 | -100.0% | -0.05% | – |
ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -81,843 | -100.0% | -0.05% | – |
WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -98,039 | -100.0% | -0.06% | – |
NXTC | Exit | NEXTCURE INC | $0 | – | -71,435 | -100.0% | -0.06% | – |
Exit | CASI PHARMACEUTICALS INC | $0 | – | -132,014 | -100.0% | -0.07% | – | |
EOLS | Exit | EVOLUS INC | $0 | – | -45,516 | -100.0% | -0.10% | – |
INBX | Exit | INHIBRX INC | $0 | – | -49,372 | -100.0% | -0.10% | – |
RCUS | Exit | ARCUS BIOSCIENCES INCcall | $0 | – | -23,200 | -100.0% | -0.11% | – |
ATHA | Exit | ATHIRA PHARMA INCput | $0 | – | -199,500 | -100.0% | -0.11% | – |
CFRX | Exit | CONTRAFECT CORPput | $0 | – | -200,000 | -100.0% | -0.11% | – |
SNPX | Exit | SYNAPTOGENIX INC | $0 | – | -121,191 | -100.0% | -0.11% | – |
Exit | PARDES BIOSCIENCES INC | $0 | – | -223,934 | -100.0% | -0.12% | – | |
ALRN | Exit | AILERON THERAPEUTICS INC | $0 | – | -2,892,316 | -100.0% | -0.14% | – |
GMTX | Exit | GEMINI THERAPEUTICS INC | $0 | – | -443,096 | -100.0% | -0.14% | – |
AYLA | Exit | AYALA PHARMACEUTICALS INC | $0 | – | -697,316 | -100.0% | -0.14% | – |
RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -702,773 | -100.0% | -0.14% | – |
FULC | Exit | FULCRUM THERAPEUTICS INCcall | $0 | – | -182,200 | -100.0% | -0.16% | – |
CMRX | Exit | CHIMERIX INC | $0 | – | -441,203 | -100.0% | -0.17% | – |
MRUS | Exit | MERUS N V | $0 | – | -53,703 | -100.0% | -0.22% | – |
RCUS | Exit | ARCUS BIOSCIENCES INCput | $0 | – | -50,000 | -100.0% | -0.23% | – |
Exit | AADI BIOSCIENCE INC | $0 | – | -412,343 | -100.0% | -0.23% | – | |
VBLT | Exit | VASCULAR BIOGENICS LTD | $0 | – | -830,007 | -100.0% | -0.24% | – |
DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -316,939 | -100.0% | -0.26% | – |
ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -375,000 | -100.0% | -0.27% | – |
BBIO | Exit | BRIDGEBIO PHARMA INCcall | $0 | – | -200,000 | -100.0% | -0.33% | – |
APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -41,900 | -100.0% | -0.34% | – |
ITOS | Exit | ITEOS THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -0.38% | – |
ACET | Exit | ADICET BIO INC | $0 | – | -143,214 | -100.0% | -0.38% | – |
ATHA | Exit | ATHIRA PHARMA INCcall | $0 | – | -784,200 | -100.0% | -0.44% | – |
INSM | Exit | INSMED INC | $0 | – | -125,000 | -100.0% | -0.45% | – |
BPMC | Exit | BLUEPRINT MEDICINES CORPcall | $0 | – | -64,000 | -100.0% | -0.59% | – |
KWEB | Exit | KRANESHARES TRcsi chi internet | $0 | – | -100,000 | -100.0% | -0.60% | – |
VRDN | Exit | VIRIDIAN THERAPEUTICS INCcall | $0 | – | -300,000 | -100.0% | -0.63% | – |
NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -38,600 | -100.0% | -0.69% | – |
PFE | Exit | PFIZER INC | $0 | – | -80,000 | -100.0% | -0.76% | – |
HRMY | Exit | HARMONY BIOSCIENCES HLDGS IN | $0 | – | -86,035 | -100.0% | -0.76% | – |
Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -246,554 | -100.0% | -0.87% | – | |
GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -86,865 | -100.0% | -0.88% | – |
ICPT | Exit | INTERCEPT PHARMACEUTICALS INcall | $0 | – | -350,000 | -100.0% | -0.88% | – |
PCVX | Exit | VAXCYTE INC | $0 | – | -225,991 | -100.0% | -0.90% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -60,000 | -100.0% | -0.91% | – |
APLS | Exit | APELLIS PHARMACEUTICALS INCcall | $0 | – | -123,200 | -100.0% | -1.02% | – |
ALNY | Exit | ALNYLAM PHARMACEUTICALS INCput | $0 | – | -39,900 | -100.0% | -1.06% | – |
LNTH | Exit | LANTHEUS HLDGS INCcall | $0 | – | -100,000 | -100.0% | -1.20% | – |
SAGE | Exit | SAGE THERAPEUTICS INCcall | $0 | – | -250,000 | -100.0% | -1.47% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -106,700 | -100.0% | -1.61% | – |
KZR | Exit | KEZAR LIFE SCIENCES INCcall | $0 | – | -1,075,300 | -100.0% | -1.62% | – |
UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -40,000 | -100.0% | -1.72% | – |
VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -40,000 | -100.0% | -2.06% | – |
KRTX | Exit | KARUNA THERAPEUTICS INCput | $0 | – | -100,000 | -100.0% | -2.31% | – |
KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -2.31% | – |
AXSM | Exit | AXSOME THERAPEUTICS INCcall | $0 | – | -350,000 | -100.0% | -2.44% | – |
CLDX | Exit | CELLDEX THERAPEUTICS INC NEWcall | $0 | – | -506,500 | -100.0% | -2.49% | – |
CLDX | Exit | CELLDEX THERAPEUTICS INC NEWput | $0 | – | -616,700 | -100.0% | -3.03% | – |
AMGN | Exit | AMGEN INCcall | $0 | – | -100,000 | -100.0% | -4.44% | – |
ALNY | Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -291,300 | -100.0% | -7.75% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
XENON PHARMACEUTICALS INC | 15 | Q2 2023 | 1.5% |
OCULAR THERAPEUTIX INC | 15 | Q3 2023 | 1.4% |
SAREPTA THERAPEUTICS INC | 14 | Q3 2023 | 6.4% |
X4 PHARMACEUTICALS INC - PIPE | 14 | Q2 2023 | 1.4% |
PROTARA THERAPEUTICS INC | 14 | Q3 2023 | 1.2% |
SPDR SER TR | 13 | Q3 2023 | 9.0% |
VAXCYTE INC | 13 | Q3 2023 | 2.9% |
TRACON PHARMACEUTICALS INC | 13 | Q3 2023 | 1.4% |
MILESTONE PHARMACEUTICALS IN | 13 | Q3 2023 | 1.7% |
BELLUS HEALTH INC NEW | 13 | Q1 2023 | 1.8% |
View Ikarian Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Milestone Pharmaceuticals Inc. | February 14, 2023 | 460,416 | 1.3% |
X4 Pharmaceuticals, Inc | February 14, 2023 | 349,133 | 0.3% |
aTYR PHARMA INC | February 14, 2022 | 35,048 | 0.1% |
Cyclacel Pharmaceuticals, Inc. | February 14, 2022 | 99,422 | 1.0% |
KalVista Pharmaceuticals, Inc. | February 14, 2022 | 36,576 | 0.2% |
Lyra Therapeutics, Inc. | February 14, 2022 | 394,536 | 3.0% |
Odonate Therapeutics, Inc. | February 14, 2022 | 1,340,631 | 3.5% |
Protara Therapeutics, Inc. | February 14, 2022 | 279,256 | 2.5% |
Science 37 Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
scPharmaceuticals Inc. | February 14, 2022 | 901,362 | 3.3% |
View Ikarian Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-04-05 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
View Ikarian Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.